Brenntag AG (OTCMKTS:BNTGY – Get Free Report) has received an average recommendation of “Reduce” from the nine analysts that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell rating and six have issued a hold rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $12.80.
A number of equities analysts have recently commented on the company. Barclays raised Brenntag to a “hold” rating in a report on Thursday, January 15th. Citigroup restated a “neutral” rating on shares of Brenntag in a research note on Friday, November 14th. Morgan Stanley cut Brenntag from an “equal weight” rating to an “underweight” rating in a research report on Tuesday, January 6th. UBS Group downgraded shares of Brenntag from a “hold” rating to a “sell” rating in a report on Friday, October 10th. Finally, Zacks Research raised shares of Brenntag from a “strong sell” rating to a “hold” rating in a research note on Friday, October 17th.
Read Our Latest Report on Brenntag
Brenntag Stock Up 0.3%
Brenntag (OTCMKTS:BNTGY – Get Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.01). Brenntag had a return on equity of 9.14% and a net margin of 2.66%.The business had revenue of $4.31 billion during the quarter, compared to the consensus estimate of $4.32 billion. Analysts anticipate that Brenntag will post 0.9 earnings per share for the current fiscal year.
Brenntag Company Profile
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Featured Stories
- Five stocks we like better than Brenntag
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
